Human medicines

Safety information on the quality defect/recall of "Amoxilan 250 mg/5 ml - Trockensaft" New

Safety warnings | Medicines | 12/04/2024
Further information and safety information about the quality defect/recall of "Amoxilan 250 mg/5 ml - Trockesaft"
Safety information on the quality defect/recall of "Amoxilan 250 mg/5 ml - Trockensaft" Read more

Amoxilan 250 mg/5 ml - Trockensaft New

Recall | Medicines | 12/04/2024
Recall due to possible contamination with glass splinters
Amoxilan 250 mg/5 ml - Trockensaft Read more

Tetracaine hydrochloride, active ingredient New

Recall | Medicines | 09/04/2024
Recall due to appearance of the solution
Tetracaine hydrochloride, active ingredient Read more
News

Medicinal products containing estragole

messages in brief | 15/03/2024
The committee on herbal medicinal products (HMPC) of the European Medicines Agency (EMA) published the revised Public Statement on the use of herbal medicinal products1 containing estragole.
Medicinal products containing estragole Read more

Soolantra 10 mg/g Creme

Recall | Medicines | 08/03/2024
Recall due to exceeding the limit value of the parameter "known impurities"
Soolantra 10 mg/g Creme Read more

Flux Hexal 20 mg – Kapseln and Fluoxetin 1A Pharma 20 mg – Kapseln

Recall | Medicines | 20/02/2024
Recall due to nitrosamine contamination above the permitted daily dose
Flux Hexal 20 mg – Kapseln and Fluoxetin 1A Pharma 20 mg – Kapseln Read more

Sycrest Sublingualtabletten

Recall | Medicines | 01/02/2024
Recall due to a possible product quality problem during production
Sycrest Sublingualtabletten Read more
Email

Further inquiry note